Role of high-mobility group box 1 protein in the pathogenesis of intestinal barrier injury in rats with severe acute pancreatitis

Pancreas

Volumn 39, Issue 2, 2010, Pages 216-223

  Luan, Zheng Gang ^a   Zhang, Hao ^a   Ma, Xiao Chun ^a   Zhang, Cheng ^a   Guo, Ren Xuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Ethyl pyruvate; High mobility group box 1; Intestinal mucosa; Severe acute pancreatitis

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); AMYLASE; ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; MYELOPEROXIDASE; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENTERITIS; ILEUM MUCOSA; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; INTESTINE MUCOSA; MALE; MORPHOMETRICS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; UPREGULATION;

ACUTE DISEASE; AMINE OXIDASE (COPPER-CONTAINING); AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BACTERIAL TRANSLOCATION; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENDOTOXINS; HMGB1 PROTEIN; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; NEUTROPHIL INFILTRATION; PANCREAS; PANCREATITIS; PERMEABILITY; PEROXIDASE; PYRUVATES; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TAUROCHOLIC ACID; TIME FACTORS; UP-REGULATION;

EID: 77649269030     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bab5c5     Document Type: Article

References (43)

1. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas. 2003;26:122-129.
2. Lankisch PG, Lerch MM. Pharmacological prevention and treatment of acute pancreatitis: where are we now? Dig Dis. 2006;24:148-159.
3. Buter A, Imrie CW, Carter CR, et al. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg. 2002;89:298-302.
4. Yasuda T, Ueda T, Takeyama Y, et al. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas. 2006;33:359-363.
5. Medich DS, Lee TK, Melhem MF, et al. Pathogenesis of pancreatic sepsis. Am J Surg. 1993;165:46-52.
6. Gianotti L, Munda R, Alexander JW, et al. Bacterial translocation: a potential source for infection in acute pancreatitis. Pancreas. 1993;8: 551-558.
7. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;20:411-417.
8. Cicalese L, Sahai A, Sileri P, et al. Acute pancreatitis and bacterial translocation. Dig Dis Sci. 2001;46:1126-1132.
9. Sawa H, Ueda T, Takeyama Y, et al. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol. 2006;12:7666-7670.
10. Arendt T, Wendt M, Olszewski M, et al. Cerulein-induced acute pancreatitis in ratsVdoes bacterial translocation occur via a transperitoneal pathway? Pancreas. 1997;15:291-296.
11. Tarpila E, Nystrom PO, Franzen L, et al. Bacterial translocation during acute pancreatitis in rats. Eur J Surg. 1993;159:109-113.
12. Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol. 2003;284:C870-C879.
13. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-195.
14. Yang H, Tracey KJ. High mobility group box 1 (HMGB1). Crit Care Med. 2005;33:S472-S474.
15. Aho HJ, Kskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol. 1980;15:411-416.
16. KusskeAM, Rongione AJ, AshleySW, et al. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery. 1996;120:284-289.
17. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985;14:156-167.
18. Nobumichi H, Masaharu N, Manabtu N, et al. Structural and functional alterations in the gut of parenterally or enterally fed rats. J Surg Res. 1989;47:129-132.
19. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Arch Surg. 1993;128:586-590.
20. Eland IA, Sturkenboom MJ, Wilson JH, et al. Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol. 2000;35:1110-1116.
21. Toh SK, Phillips S, Johnson CD. A prospective audit against national standards of the presentation and management of acute pancreatitis in the south of England. Gut. 2000;46:239-243.
22. Compañy L, Sáez J, Martínez J, et al. Factors predicting mortality in severe acute pancreatitis. Pancreatology. 2003;3:144-148.
23. Ammori BJ, Leeder PC, King RF, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg. 1999;3:252-262.
24. Bradley EL 3rd, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg. 1991;161:19-24.
25. Braga M, Gianotti L, Gentilini O, et al. Feeding the gut early after digestive surgery: results of a nine-year experience. Clin Nutr. 2002;21:59-65.
26. Juvonen PO, Alhava EM, Takala JA. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol. 2000;12:1314-1318.
27. McNaught CE, Woodcock NP, Mitchell CJ, et al. Gastric colonisation, intestinal permeability and septic morbidity in acute pancreatitis. Pancreatology. 2002;2:463-468.
28. Rahman SH, Ammori BJ, Larvin M, et al. Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response? Gut. 2003;52:270-274.
29. Wang X, Wang B, Wu J, et al. Beneficial effects of growth hormone on bacterial translocation during the course of acute necrotizing pancreatitis in rats. Pancreas. 2001;23:148-156.
30. Kouris GJ, Liu Q, Rossi H, et al. The effect of glucagon-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis. Am J Surg. 2001;181:571-575.
31. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med. 2004;255:320-331.
32. Czura CJ, Tracey KJ. Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit Care Med. 2003;31:S46-S50.
33. Ulloa L, Ochani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A. 2002;99:12351-12356.
34. Andersson U, Tracey KJ. HMGB1 in sepsis. Scand J Infect Dis. 2003;35:576-584.
35. Kim JY, Park JS, Strassheim D, et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol. 2005;288:L958-L965.
36. Ohashi S, Nishio A, Nakamura H, et al. Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G772-G781.
37. Biegacski T, Kusche J, Lorenz W, et al. Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta. 1983;756:196-203.
38. Luk GD, Bayless TM, Baylin SB. Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity. J Clin Invest. 1980;66:66-70.
39. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med. 2003;9:516-524.
40. Fink MP. Ethyl pyruvate: a novel anti-inflammatory agent. Crit Care Med. 2003;31:S51-S56.
41. Cheng BQ, Liu CT, Li WJ, et al. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas. 2007;35:256-261.
42. Sappington PL, Yang R, Yang H, et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology. 2002;123:790-802.
43. Minor K, Liu S, Delude RL, et al. HMGB1 increases gut permeability through the modulation of tight junction proteins. Crit Care Med. 2007;35:A32.